Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease
Immunity · 2024-10 · 57 (10) · 2310-2327.e6
DOI: 10.1016/j.immuni.2024.08.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2024-10. Verfasst von Wei Guo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China…. Hauptthemen laut MEDLINE: Receptors, Notch, Signal Transduction, Immunoglobulin J Recombination Signal Sequence-Binding Protein, Macrophages. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
The liver macrophage population comprises resident Kupffer cells (KCs) and monocyte-derived macrophages with distinct pro- or anti-inflammatory properties that affect the severity and course of liver diseases. The mechanisms underlying macrophage differentiation and functions in metabolic dysfunction-associated steatotic liver disease and/or steatohepatitis (MASLD/MASH) remain mostly unknown. Using single-cell RNA sequencing (scRNA-seq) and fate mapping of hepatic macrophage subpopulations, we unraveled the temporal and spatial dynamics of distinct monocyte and monocyte-derived macrophage subsets in MASH. We revealed a crucial role for the Notch-Recombination signal binding protein for immunoglobulin kappa J region (RBPJ) signaling pathway in controlling the monocyte-to-macrophage transition, with Rbpj deficiency blunting inflammatory macrophages and monocyte-derived KC differentiation and conversely promoting the emergence of protective Ly6Clo monocytes. Mechanistically, Rbpj deficiency promoted lipid uptake driven by elevated CD36 expression in Ly6Clo monocytes, enhancing their protective interactions with endothelial cells. Our findings uncover the crucial role of Notch-RBPJ signaling in monocyte-to-macrophage transition and will aid in the design of therapeutic strategies for MASH treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of General Surgery, Pancreatic Disease Center, Ruijin Hos…
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Inserm U1015, Gustave Roussy, Villejuif 94800, France.
- Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7YH, UK.
- Department of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- Institute for Immunology and School of Basic Medical Sciences, Tsinghua University, Beijing, China.
Zitieren
APA
Guo, W., Li, Z., Anagnostopoulos, G., Kong, W. T., Zhang, S., Chakarov, S., Shin, A., Qian, J., Zhu, Y., Bai, W., Cexus, O., Nie, B., Wang, J., Hu, X., Blériot, C., Liu, Z., Shen, B., Venteclef, N., Su, B., & Ginhoux, F. (2024). Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease. Immunity, 57(10), 2310-2327.e6. https://doi.org/10.1016/j.immuni.2024.08.016
Vancouver
Guo W, Li Z, Anagnostopoulos G, Kong WT, Zhang S, Chakarov S, et al. Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease. Immunity. 2024;57(10):2310-2327.e6. doi:10.1016/j.immuni.2024.08.016
BibTeX
@article{Guo2024,
author = {Guo, Wei and Li, Ziyi and Anagnostopoulos, Gerasimos and Kong, Wan Ting and Zhang, Shuangyan and Chakarov, Svetoslav and Shin, Amanda and Qian, Jiawen and Zhu, Yiwen and Bai, Wenjuan and Cexus, Olivier and Nie, Bin'en and Wang, Jing and Hu, Xiaoyu and Blériot, Camille and Liu, Zhaoyuan and Shen, Baiyong and Venteclef, Nicolas and Su, Bing and Ginhoux, Florent},
title = {Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease},
journal = {Immunity},
year = {2024},
volume = {57},
number = {10},
pages = {2310--2327.e6},
doi = {10.1016/j.immuni.2024.08.016}
}
EUVIMED